drugset

drugset / Trial / NCT00439686

Study of ZIO-201 in Advanced Sarcoma

NCT00439686 ↗

Phase 1/2 Completed 53 enrolled Alaunos Therapeutics

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The study of safety of Isophosphoramide Mustard (IPM) in the treatment of advanced sarcoma.

Timeline

Start: 2006-02
Primary completion: 2008-06
Completion: 2013-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Palifosfamide	Small molecule	—	Intravenous

Indications